2002
DOI: 10.1080/ejc.7.1.36.40
|View full text |Cite
|
Sign up to set email alerts
|

Clinical experience with Norplant®subdermal implant system as long-term contraception during adolescence

Abstract: This preliminary study has shown that Norplant is acceptable as a contraceptive method among adolescents in Greece and can be prescribed safely.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In a non-comparative study, one-third of levonorgestrelonly implant users (mean age 18.2 years) reported weight gain with 6 months' use, averaging an increase of 3.74 kg. 139 Few etonorgestrel users reported weight gain (6.9%), yet the measured weight gain was at least 6.8 kg over 2 years. 140 Increased weight has also been noted with the levonorgestrel implant.…”
Section: Weight Gainmentioning
confidence: 97%
“…In a non-comparative study, one-third of levonorgestrelonly implant users (mean age 18.2 years) reported weight gain with 6 months' use, averaging an increase of 3.74 kg. 139 Few etonorgestrel users reported weight gain (6.9%), yet the measured weight gain was at least 6.8 kg over 2 years. 140 Increased weight has also been noted with the levonorgestrel implant.…”
Section: Weight Gainmentioning
confidence: 97%